It is well known that one of the leading causes of death among the population is cardiovascular disease, and they are often complicated by CHF. In European countries, the prevalence of CHF is 2.1%, with 90% of women over the age of 70 and 75% of men. In the United States, these numbers range from 1–1.5% and occur in 10% of the population over the age of 60. According to a number of leading researchers around the world, the inclusion of concomitant diseases in CHF not only worsens its overall outcome, increases the number and duration of hospital treatments , but in some cases is also the leading cause of death. Some authors compare the dynamics of deaths observed in CHF with deaths due to oncological diseases.